Latest Food and Drug Administration Stories
The U.S. Food and Drug Administration (FDA) has warned about the risks of dietary supplements containing live bacteria or yeast being taken by patients with compromised immune systems.
LEXINGTON, Mass., Dec.
KENNEWICK, Wash., Dec.
AUSTIN, Texas, Dec. 23, 2014 /PRNewswire/ -- Vermillion, Inc.
IGI Filed Eleven ANDAs in 2014, and IGI Now Has Twenty-Two Applications Pending at the FDA BUENA, N.J., Dec. 23, 2014 /PRNewswire/ -- IGI Laboratories, Inc.
Patient recruitment in the WISE clinical study continues CAESAREA, Israel, December 22, 2014 /PRNewswire/ -- Allium Medical (TASE: ALMD), a medical device company
PITTSBURGH, Dec. 22, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced the U.S.
First-ever clearance of its kind in the US creates an important new option for patients and providers to perform home hemodialysis overnight while sleeping LAWRENCE, Mass., Dec.
Flavr Savr, also known as CGN-89564, a genetically modified tomato, was the first commercially grown genetically engineered food to be granted a license for human consumption. It was produced by the Californian company Calgene, and submitted to the U.S. Food and Drug Administration in 1992. On May 18, 1994, the FDA completed its evaluation of the Flavr Savr tomato and the usage of APH(3’)II, concluding that the tomato “is as safe as tomatoes bred by conventional means” and “that the...
The Chilean sea bass is the North American name for the Patagonian toothfish. The Chilean sea bass name derived in 1977 from Lee Lantz, a fish wholesaler looking for a more attractive name for the American fish market. In 1994 the Food and Drug Administration (FDA) accepted the Chilean sea bass as an alternative name for the Patagonian toothfish. This species is native to the southern Pacific, Atlantic, and Indian Oceans, around seamounts and continental shelves in the colder waters. The...